Home Biosimilar Antibodies Others Others Feladilimab (Anti-ICOS / CD278)
For research use only. Not for use in humans.

Feladilimab (Anti-ICOS / CD278)

Synonyms: GSK3359609

Feladilimab (Anti-ICOS/CD278) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has potential for its use in cancer research. MW: 145.5 KD.

Feladilimab (Anti-ICOS / CD278)

Quality Control

Batch: A246201 Purity: 99% Protein concentration: 8.65mg/ml Endotoxin Level: ＜1EU/mg
99

Mechanism of Action

Description
Feladilimab (Anti-ICOS/CD278) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has potential for its use in cancer research. MW: 145.5 KD.

Product Details

CAS No. 2252518-85-5
Molecular Weight 145.5 kDa
Isotype Human IgG4PE
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.